JP5475995B2 - 動的核分極（ｄｎｐ）法 - Google Patents

動的核分極（ｄｎｐ）法 Download PDF

Info

Publication number
JP5475995B2
JP5475995B2 JP2008543224A JP2008543224A JP5475995B2 JP 5475995 B2 JP5475995 B2 JP 5475995B2 JP 2008543224 A JP2008543224 A JP 2008543224A JP 2008543224 A JP2008543224 A JP 2008543224A JP 5475995 B2 JP5475995 B2 JP 5475995B2
Authority
JP
Japan
Prior art keywords
sample
composition
polarization
pyruvate
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008543224A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009517688A5 (https=
JP2009517688A (ja
Inventor
サニング，ミッケル
セルヴィン，ロルフ
Original Assignee
ジーイー・ヘルスケア・アクスイェ・セルスカプ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20055681A external-priority patent/NO20055681D0/no
Priority claimed from NO20055705A external-priority patent/NO20055705D0/no
Application filed by ジーイー・ヘルスケア・アクスイェ・セルスカプ filed Critical ジーイー・ヘルスケア・アクスイェ・セルスカプ
Publication of JP2009517688A publication Critical patent/JP2009517688A/ja
Publication of JP2009517688A5 publication Critical patent/JP2009517688A5/ja
Application granted granted Critical
Publication of JP5475995B2 publication Critical patent/JP5475995B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/124—Macromolecular compounds dendrimers, dendrons, hyperbranched compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
JP2008543224A 2005-12-01 2006-12-01 動的核分極（ｄｎｐ）法 Expired - Fee Related JP5475995B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NO20055681 2005-12-01
NO20055681A NO20055681D0 (no) 2005-12-01 2005-12-01 Method of dynamic nuclear polarisation
NO20055705 2005-12-02
NO20055705A NO20055705D0 (no) 2005-12-02 2005-12-02 Method of dynamic nuclear polarisation
NO20063119 2006-07-05
NO20063119 2006-07-05
PCT/NO2006/000449 WO2007064226A2 (en) 2005-12-01 2006-12-01 Method of dynamic nuclear polarisation (dnp) using a trityl radical and a paramagnetic metal ion

Publications (3)

Publication Number Publication Date
JP2009517688A JP2009517688A (ja) 2009-04-30
JP2009517688A5 JP2009517688A5 (https=) 2012-08-23
JP5475995B2 true JP5475995B2 (ja) 2014-04-16

Family

ID=38092667

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008543224A Expired - Fee Related JP5475995B2 (ja) 2005-12-01 2006-12-01 動的核分極（ｄｎｐ）法

Country Status (10)

Country Link
US (1) US8951502B2 (https=)
EP (1) EP1954321B1 (https=)
JP (1) JP5475995B2 (https=)
KR (2) KR20130116383A (https=)
AT (1) ATE534407T1 (https=)
AU (1) AU2006321057B2 (https=)
CA (1) CA2628539C (https=)
ES (1) ES2375089T3 (https=)
PL (1) PL1954321T3 (https=)
WO (1) WO2007064226A2 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1962912T3 (pl) * 2005-12-16 2013-03-29 Ge Healthcare As Sposób wytwarzania hiperpolaryzowanych karboksylanów amin organicznych
JP5269791B2 (ja) 2006-08-30 2013-08-21 ジーイー・ヘルスケア・アクスイェ・セルスカプ 動的核分極（ｄｎｐ）方法並びに該方法で使用するための化合物及び組成物
EP2117607A4 (en) 2007-01-11 2012-08-08 Huntington Medical Res Inst PICTURES AND METHOD FOR THEIR USE
GB0713074D0 (en) * 2007-07-05 2007-08-15 Univ London A method of hyperpolarising a magnetic resonance agent
JP2010534498A (ja) * 2007-07-26 2010-11-11 ジーイー・ヘルスケア・ユーケイ・リミテッド 方法及び該方法で使用するためのイメージング媒体
CN101854956B (zh) * 2007-08-27 2013-01-23 通用电气健康护理有限公司 包含超极化13c-醋酸盐的成像介质及其应用
EP2902041A1 (en) * 2007-12-19 2015-08-05 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
US20110038804A1 (en) * 2007-12-21 2011-02-17 Anna Gisselsson Mr imaging agent, imaging medium and methods of imaging wherein such an imaging medium is used
JP2011514313A (ja) * 2008-02-04 2011-05-06 ジーイー・ヘルスケア・リミテッド 過分極アミノ酸及びアミノスルホン酸の製造方法
JP2011511775A (ja) * 2008-02-04 2011-04-14 ジーイー・ヘルスケア・リミテッド 過分極１３ｃ−アラニンを含むｍｒ造影剤、又は画像媒体、及びそのような画像媒体を使用する画像検査法
WO2009150211A1 (en) * 2008-06-13 2009-12-17 Ge Healthcare Limited Dnp polariser and method of producing a hyperpolarised selected material
WO2010014893A2 (en) * 2008-07-31 2010-02-04 Duke University Magnetic resonance imaging and/or spectroscopy contrast agents and methods of use thereof
US8697034B2 (en) * 2008-10-10 2014-04-15 The Board Of Regents Of The University Of Texas System Hyperpolarized 89-yttrium and methods relating thereto
AU2010230330B2 (en) 2009-04-02 2015-06-25 Ge Healthcare Limited Use of a magnetic resonance imaging medium comprising hyperpolarized 13C pyruvate for the detection of inflammation or infection
SG179067A1 (en) 2009-09-10 2012-04-27 Ge Healthcare Ltd 13c-mr detection using hyperpolarised 13c-fructose
EP2494918B1 (en) * 2009-10-29 2015-08-19 Kyushu University, National University Corporation Method for detecting endogenous biomolecules
EP2348327B1 (en) 2010-01-18 2013-11-27 Bruker BioSpin AG Method for NMR measurements using dissolution dynamic nuclear polarization (DNP) with elimination of free radicals
WO2011124672A1 (en) 2010-04-08 2011-10-13 Bracco Imaging Spa Process for preparing hyperpolarized substrates and method for mri
KR101858269B1 (ko) 2010-05-03 2018-05-15 지이 헬쓰케어 리미티드 락테이트 탈수소효소 활성의 측정을 위한 과분극화된 락테이트 조영제
US20140328766A1 (en) * 2010-08-24 2014-11-06 Ge Healthcare Limited Composition and method for generating a metabolic profile using 13c-mr detection
US9738686B2 (en) 2011-07-18 2017-08-22 The Trustees of the California State University Electron spin labeled ice binding compounds used for carrying paramagnetic centers for dynamic nuclear polarization
WO2013053839A1 (en) 2011-10-12 2013-04-18 Bracco Imaging Spa Process for the preparation of hyperpolarized derivatives for use in mri analysis
WO2013083535A1 (en) 2011-12-05 2013-06-13 Bracco Imaging Spa Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation mri analysis
US9925280B2 (en) 2012-04-02 2018-03-27 Bracco Imaging S.P.A. Hyperpolarized amino acids
EP2847591A1 (en) 2012-05-07 2015-03-18 Albeda Innovation ApS Intra-operative cancer diagnosis based on a hyperpolarized marker
EP2972441B1 (en) 2013-03-14 2016-11-30 Ecole Polytechnique Fédérale de Lausanne (EPFL) Method for the generation of radicals for dynamic nuclear polarization and uses thereof for nmr, mrs and mri
US20160296645A1 (en) 2013-07-01 2016-10-13 Bracco Imaging S.P.A Hyperpolarized 1-13c-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for mr
US9642924B2 (en) 2013-08-29 2017-05-09 Duke University Contrast agents based on long-lived nuclear singlet states and related methods
EP2891500B1 (en) 2014-01-07 2018-08-01 Cambridge Enterprise Limited Contrast agent for determination of aldehyde dehydrogenase (ALDH) activity
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
CN113164628A (zh) 2018-11-23 2021-07-23 拜耳股份有限公司 造影介质制剂及其制备方法
CN120574245B (zh) * 2025-08-04 2025-12-02 中国科学院精密测量科学与技术创新研究院 一种含氟三苯甲基自由基化合物及其制备方法和应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012024A1 (en) * 1990-02-12 1991-08-22 Hafslund Nycomed Innovation Ab Triarylmethyl radicals and the use of inert carbon free radicals in mri
PH27135A (en) 1987-06-23 1993-03-16 Hafslund Nycomed Innovation Method of electron spin resonance enhanced magnetic resonance imaging
GB8817137D0 (en) 1988-07-19 1988-08-24 Nycomed As Compositions
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
GB8830215D0 (en) * 1988-12-23 1989-02-22 Hafslund Nycomed Innovation Method
US4969184A (en) * 1989-02-02 1990-11-06 Alphanet Technology Corporation Data transmission arrangement
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
GB9024528D0 (en) * 1990-11-12 1991-01-02 Instrumentarium Corp Improvements in and relating to magnetic resonance imaging
AU668691B2 (en) 1991-08-09 1996-05-16 Nycomed Innovation Ab Use of persistent free-radicals in magnetic resonance imaging
US5728370A (en) 1993-04-02 1998-03-17 Nycomed Imaging As Free Radicals
GB9704669D0 (en) 1997-03-06 1997-04-23 Nycomed Imaging As Free radicals
ES2175123T3 (es) 1995-09-08 2002-11-16 Nycomed Imaging As Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra.
AU6506598A (en) 1997-03-06 1998-09-22 Nycomed Imaging As Triarylmethyl free radicals as image enhancing agents
JP2002508687A (ja) * 1997-06-19 2002-03-19 ナイコムド イメージング エーエス 磁気共鳴（ｍｒ）イメージング剤の生体外分極を含むオーバーハウザー磁気共鳴画像（ｏｒｍｉ）法
US6278893B1 (en) 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
GB0014463D0 (en) 2000-06-14 2000-08-09 Nycomed Amersham Plc NMR Method
DK1330659T3 (da) 2000-11-03 2006-12-18 Amersham Health As Fremgangsmåde og indretning til oplösning af hyperpolariseret, fast materiale til NMR-analyser
NO20023357D0 (no) 2002-04-19 2002-07-11 Amersham Health As Blanding
NO20025738D0 (no) 2002-11-29 2002-11-29 Amersham Health As Metode
US7351402B2 (en) 2003-08-21 2008-04-01 Massachusetts Institute Of Technology Polarizing agents for dynamic nuclear polarization
US20050063491A1 (en) 2003-09-19 2005-03-24 Siemens Vdo Automotive Corporation Radio frequency signal discrimination method and system
JP2007523504A (ja) 2004-02-04 2007-08-16 松下電器産業株式会社 データ伝送用のパケット・フレームの生成方法及び装置
CN101031811A (zh) 2004-07-30 2007-09-05 通用电气医疗集团股份有限公司 肿瘤成像方法
WO2006011809A1 (en) * 2004-07-30 2006-02-02 Ge Healthcare As Method of producing a composition, composition and its use
PL1805186T3 (pl) * 2004-07-30 2015-10-30 Ge Healthcare As Rodniki i ich zastosowanie jako środków paramagnetycznych w procesie dynamicznej polaryzacji jądrowej
JP5269791B2 (ja) * 2006-08-30 2013-08-21 ジーイー・ヘルスケア・アクスイェ・セルスカプ 動的核分極（ｄｎｐ）方法並びに該方法で使用するための化合物及び組成物

Also Published As

Publication number Publication date
AU2006321057A1 (en) 2007-06-07
WO2007064226A2 (en) 2007-06-07
ATE534407T1 (de) 2011-12-15
KR20080072692A (ko) 2008-08-06
EP1954321A2 (en) 2008-08-13
EP1954321B1 (en) 2011-11-23
CA2628539C (en) 2014-04-29
JP2009517688A (ja) 2009-04-30
CA2628539A1 (en) 2007-06-07
KR20130116383A (ko) 2013-10-23
US20080260649A1 (en) 2008-10-23
ES2375089T3 (es) 2012-02-24
KR101372173B1 (ko) 2014-03-07
US8951502B2 (en) 2015-02-10
AU2006321057B2 (en) 2012-11-01
PL1954321T3 (pl) 2012-04-30
WO2007064226A3 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
JP5475995B2 (ja) 動的核分極（ｄｎｐ）法
JP2009517688A5 (https=)
JP5269791B2 (ja) 動的核分極（ｄｎｐ）方法並びに該方法で使用するための化合物及び組成物
US20100233096A1 (en) Method to produce hyperpolarised carboxylates and sulphonates
CN101970014A (zh) 包含超极化的13c-乳酸盐的成像介质及其用途
KR101413934B1 (ko) 라디칼 및 동적 핵 편극화 공정에서 상자성 물질로서의 그의 용도
CN101378784B (zh) 产生有机胺的超极化羧酸盐的方法
JP2011511775A (ja) 過分極１３ｃ−アラニンを含むｍｒ造影剤、又は画像媒体、及びそのような画像媒体を使用する画像検査法
CN101316616B (zh) 应用三苯甲基自由基和顺磁金属离子的动态核极化（dnp）的方法
WO2009150211A1 (en) Dnp polariser and method of producing a hyperpolarised selected material

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091126

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091126

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20091126

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20091126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120403

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120703

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121016

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130116

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130416

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131122

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20131129

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140108

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140207

R150 Certificate of patent or registration of utility model

Ref document number: 5475995

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees